Compensation award — excluded from discretionary-purchase analysis.
Traded Feb 27, 2026 · Filed Feb 27, 2026
A board member of Docusign sold $16K of Docusign shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$16,129
Shares × reported transaction price
85 days after results of Dec 4, 2025, 18 days before results of Mar 17, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.5% | −1.2% | +6.7% |
| 30 days | +4.3% | −4.5% | +8.9% |
| 90 days | +23.5% | +10.5% | +13.0% |
| 180 days | +43.6% | +11.8% | +31.8% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Officer sold ~$64K of Docusign
Scheduled in advanceOfficer sold ~$144K of Docusign
Scheduled in advance